News

Separation into two publicly traded companies remains on track for mid-2015.

Gains full rights to Flexus’ lead preclinical IDO1 inhibitor F001287 and the company’s broad IDO/TDO discovery program.

Transaction adds Phase 3-ready rare GI disease product to strong pipeline.

This year’s exposition welcomes 127 first-time exhibiting companies.

Patent covers the use of precipitation stabilising additives for manufacture of dry powders of therapeutic proteins.

Discovery of Gomafu function increases understanding of its role in psychiatric disease [US] and Australian scientists have found the mechanism a novel gene uses to affect brain function and elicit behavior related to neuropsychiatric disease.

Brown University scientists have mapped the similarities and the differences in the brain between the two different kinds of extroverts: "agentic" go-getters and "affiliative" people persons.

Researchers at the Institute for Autism Research at Canisius College have found a unique emotion recognition treatment highly effective for high-functioning children with autism spectrum disorder (HFASD).

Lemaître to join Link Technologies Ltd. as non-executive Director.

Professor Masaharu Seno at the Department of Biotechnology of Okayama University, reports that cancer stem cells produced from mouse iPS cells are actually necessary for the maintenance of the cancer cells themselves.